Article thumbnail

CT imaging in pre-therapeutic assessment of lung cancer.

By C. Beigelman-Aubry, V. Dunet and A.L. Brun


Lung cancer, the most frequent cancer worldwide, is the fourth most frequent cancer in France, with an overall 5-year survival rate of about 15%, directly correlated to the stage of disease at the time of diagnosis and its treatment. The objective of this article is to describe the role, contributions and pitfalls of computed tomography (CT) in clinical TNM staging, primarily to identify patients eligible for curative surgery. TNM staging criteria, last updated in 2009, are discussed along with the new proposals for the 8th edition to be published late 2016. The most crucial CT features for pre-therapy assessment are highlighted

Topics: CT scan; Lung cancer; Thorax
Publisher: 'Elsevier BV'
Year: 2016
DOI identifier: 10.1016/j.diii.2016.07.010
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.